Comorbidities and medications of patients with chronic hepatitis C under specialist care in the UK.
Designing services with the capacity and expertise to meet the needs of the chronic hepatitis C (CHC) population in the era of direct acting antivirals (DAAs), and widening access to such treatments, requires detailed understanding of the characteristics and healthcare needs of the existing patient population. In this retrospective analysis of data from the National HCV Research UK Biobank between March 2012 and October 2014, the characteristics of the CHC population currently under specialis...Expand abstract
- Publication status:
- Peer review status:
- Peer reviewed
(Version of record, pdf, 452.8KB)
- Publisher copy:
- Copyright holder:
- Walker et al
- Copyright date:
- © 2017 The Authors. Journal of Medical Virology Published by Wiley Periodicals, Inc. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record